NVIV - InVivo Therapeutics Holdings Corp.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. Estimate-0.16-0.17-0.83-0.61
Low Estimate-0.16-0.17-0.83-0.61
High Estimate-0.16-0.17-0.83-0.61
Year Ago EPS-0.17-0.2-0.76-0.83
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.19-0.22-0.21-0.22
EPS Actual-0.17-0.2-0.2-0.28
Difference0.020.020.01-0.06
Surprise %10.50%9.10%4.80%-27.30%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.16-0.17-0.83-0.61
7 Days Ago-0.16-0.17-0.83-0.61
30 Days Ago-0.17-0.17-0.78-0.64
60 Days Ago-0.17-0.17-0.78-0.64
90 Days Ago-0.17-0.17-0.78-0.64
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/AN/A1
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesNVIVIndustrySectorS&P 500
Current Qtr.5.90%N/AN/A0.23
Next Qtr.15.00%N/AN/A0.24
Current Year-9.20%N/AN/A0.08
Next Year26.50%N/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A